Sort
4,870 grants matching “glp 1”
IGF::OT::IGF DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP) TASK ORDER #01: PERFORMANCE ACTIVITY 1 TECHNICAL SUPPORT (1/15/15 / 1/14/16)
$32,366John Reilly · Albany Molecular Research, Inc. · N01 · FY2022 · DA
Drug Development of GLP-1 receptor agonists
$32,038Josephine Egan · National Institute On Aging · ZIA · FY2015 · AG
EXENATIDE (BYETTA) VS PRAMLINTIDE (SYMLIN)
$31,661Luisa M Rodriguez · Baylor College Of Medicine · M01 · FY2011 · RR
High fat diet induced remodeling of preproglucagon neuronal control of feeding behavior
$31,492Payam Fathi · Vanderbilt University · F31 · FY2022 · DK
IGF::OT::IGF DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP) TASK ORDER #01: PERFORMANCE ACTIVITY 1 TECHNICAL SUPPORT (1/15/15 / 1/14/16)
$31,473John Reilly · Albany Molecular Research, Inc. · N01 · FY2021 · DA
Hormonal Modulation of Peripheral Taste Sensitivity
$31,113Amanda Elson · University Of Maryland Baltimore · F31 · FY2010 · DC
MOLECULAR SWITCH VACCINES FOR BIODEFENSE, CANCER, AND INFECTIOUS DISEASE
$30,914Robert E Lanford · Texas Biomedical Research Institute · P51 · FY2011 · RR
Hormonal Modulation of Peripheral Taste Sensitivity
$30,909Amanda Elson · University Of Maryland Baltimore · F31 · FY2009 · DC
DIET/GROWTH FACTOR MECHANISMS OF GUT ADAPTATION
$30,798Emory University · R01 · FY2002 · DK
High fat diet induced remodeling of preproglucagon neuronal control of feeding behavior
$30,776Payam Fathi · Vanderbilt University · F31 · FY2021 · DK
CLINICAL TRIAL: EFFECTS OF PIOGLITAZONE ON INCRETIN AXIS IN PTS W TYPE 2 DIABETE
$30,774Richard E Pratley · University Of Vermont & St Agric College · M01 · FY2009 · RR
IGF::OT::IGF DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP) TASK ORDER #01: PERFORMANCE ACTIVITY 1 TECHNICAL SUPPORT (1/15/15 / 1/14/16)
$30,608John Reilly · Albany Molecular Research, Inc. · N01 · FY2020 · DA
Cardiovascular effects of GLP-1 in obesity/metabolic syndrome
$30,604Johnathan D Tune · Indiana University Indianapolis · R01 · FY2013 · HL
Glucagon-like peptide-1 in brainstem integration of energy balance control
$30,566Elizabeth Genevieve Mietlicki-Baase · University Of Pennsylvania · F32 · FY2014 · DK
Lateral Septal GLP-1 pathways
$30,486Sarah Terrill · Florida State University · F31 · FY2018 · DK
A Novel Immunological Probiotic for Treating Inflammatory Bowel Disease
$30,223Gary Fanger · Rise Therapeutics, Llc · R44 · FY2022 · DK
A Graphene Nanoparticle-Based X-ray Computed Tomography Contrast Agent ForSubjects At Risk for Contrast Induced Nephropathy
$30,000Jimmy Deon Toussaint · Theragnostic Technologies, Inc. · R43 · FY2017 · DK
Repositioning Gliptins for Parkinson's Disease Treatment
$30,000Barry J Hoffer · Case Western Reserve University · R01 · FY2018 · NS
IGF::OT::IGF DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP) TASK ORDER #01: PERFORMANCE ACTIVITY 1 TECHNICAL SUPPORT (1/15/15 / 1/14/16)
$29,769John Reilly · Albany Molecular Research, Inc. · N01 · FY2019 · NS
Neurobiological mechanisms of nicotine reinforcement: Role of the nucleus tractus
$29,232Luis Miguel Tuesta · Scripps Florida · F31 · FY2012 · DA
Central Effects of Glucagon-like peptide-1 on Gustatory Reward
$29,010Carolyn E. Pritchett · Pennsylvania State Univ Hershey Med Ctr · F31 · FY2011 · DC
IGF::OT::IGF DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP) TASK ORDER #01: PERFORMANCE ACTIVITY 1 TECHNICAL SUPPORT (1/15/15 / 1/14/16)
$28,963John Reilly · Albany Molecular Research, Inc. · N01 · FY2018 · NS
Neurobiological mechanisms of nicotine reinforcement: Role of the nucleus tractus
$28,800Luis Miguel Tuesta · Scripps Florida · F31 · FY2011 · DA
Defining alpha-cell PC1/3 expression regulation for type 2 diabetes
$28,613Marlena Meta Holter · Cornell University · F30 · FY2023 · DK
IGF::OT::IGF DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP) TASK ORDER #01: PERFORMANCE ACTIVITY 1 TECHNICAL SUPPORT (1/15/15 / 1/14/16)
$28,163John Reilly · Albany Molecular Research, Inc. · N01 · FY2017 · NS